A dry cough is a different page
Bradykinin cough is miserable and class-wide. It is not airway swell. Use the cough chip and who writes a switch for the tickle. Use this page only for swell.
Pregnancy is still a boxed stop. Labs still matter after the ACE comes off. The renal-lane signal watches potassium on whatever replaces it.
Do not trial a second ACE stamp
VASOTEC is contraindicated after angioedema related to any ACE inhibitor, and in hereditary or idiopathic angioedema. Switching Hypernil to lisinopril or to Vasotec is not a test. It is a rechallenge.
A history of angioedema unrelated to ACE inhibitors still raises risk on this class. Say that history out loud before anyone writes 20 mg.
Belly pain can be intestinal angioedema
ACE inhibitors have a labelled intestinal angioedema picture: abdominal pain, with or without nausea, sometimes without any prior facial swell, and normal C1 esterase in the cases described. Imaging or surgery made some of those diagnoses. Symptoms resolved after the ACE stopped.
Put that on the differential when someone on 20 mg has unexplained pain. It is rare. It is not a gas shrug.
The labelled picture is not week one only
Angioedema, including laryngeal edema, may occur at any time during treatment. Patients are told to report swelling of face, extremities, eyes, lips, or tongue, and difficulty swallowing or breathing, and to take no more drug until they have spoken with the prescriber.
A home antihistamine trial is not that visit. Airway swell can be fatal. The panel opens on this stop for a reason.
Thirty-six hours off before sacubitril/valsartan
Do not give VASOTEC within 36 hours of switching to or from sacubitril/valsartan. The combination with a neprilysin inhibitor is contraindicated. Write the last 20 mg hour on paper. 'Sometime last night' is how overlaps get charted.
MTOR inhibitors (sirolimus, everolimus, temsirolimus) also raise angioedema risk next to an ACE. Name those if they are on the list. This is not a cough-chip job.
The higher rate is a counseling fact
Angioedema has been reported more often in Black patients on ACE inhibitors than in non-Black patients. Blood-pressure effect was also smaller, on average, in Black patients in controlled ACE trials. Those are two labelled sentences.
They are not a reason to shrug lip swell as 'allergies.' They are not a reason this page will invent a racial dose. Heart-failure indications still belong to the clinician who owns them.